What's new?

Sofinnova Partners Announces Sale of Corvidia Therapeutics to Novo Nordisk

Novo Nordisk acquires Corvidia for $2.1B with an upfront payment of $725M in cash   Sofinnova Partners co-founded Corvidia as its sole seed financial investor in 2015 with serial entrepreneur Michael Davidson   PARIS, France – June 11, 2020 - Sofinnova Partners, a leading European life sciences venture capital firm...

Mainstay Medical Announces U.S. FDA Approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain

• U.S. commercialization expected to begin in the first half of 2021   • Continues positive momentum for Mainstay, with increasing commercial footprint in Europe and expected launch in Australia in early 2021   June 22, 2020 02:00 AM Eastern Daylight Time DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc (“Mai...

Shockwave Announces Pricing of Public Offering of Common Stock

June 16, 2020 at 8:20 PM EDT   SANTA CLARA, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (“Shockwave”) (Nasdaq: SWAV) today announced the pricing of its public offering of 1,700,000 shares of its common stock at a price to the public of $45.75 per share.

Inventiva’s lanifibranor meets the primary and key secondary endpoints in the Phase IIb NATIVE clinical trial in non-alcoholic steatohepatitis (NASH)

Daix (France), June 15, 2020 – Inventiva (Euronext: IVA), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced positive toplin...

Epsilen Bio appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board

Company announces strategic collaboration with SR-Tiget   MILAN, Italy – June 15, 2020 -- Epsilen Bio, a biotechnology company developing transformative therapies for patients affected by underserved medical conditions through stable epigenetic silencing of genes involved in pathological processes, announced today ...

Synthace and Tecan Announce Collaboration to Accelerate Purification Optimization in Process Development through Augmented Lab Automation

June 11, 2020 05:10 AM Eastern Daylight Time LONDON--(BUSINESS WIRE)--Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, and the Tecan Group (SIX Swiss Exchange: TECN) announce a partnership to deepen the integration betwe...

AFYREN and the AFTER-BIOCHEM European consortium obtain a funding of 20 million euros for the industrial production of new bio-based products

Paris, Thursday June 11th 2020   Highlights   • €20 million European grant of private-public partnership “Bio Based Industry Joint Undertaking” • Construction of first flagship biorefinery confirmed through its affiliate AFYREN NEOXY • 50+ direct jobs in Northeast France and up to 200 indirect jobs expected   AFYRE...

Protera Closes $5.6M Series A Financing led by Sofinnova Partners

Startup to use funds to advance its AI-driven design and commercialization of new proteins to enable sustainable solutions   SANTIAGO, Chile and PARIS, France – June 10, 2020 – Protera, an AI-driven startup designing and developing new proteins to enable a wide range of natural and sustainable solutions, announced ...

Biotalys Expands Executive Team and Establishes U.S. Headquarters to Strengthen North American Presence

Appoints Diego Angelo as Chief Business Officer and Head of Biotalys, Inc. to prepare for biofungicide launch   GHENT, Belgium and RESEARCH TRIANGLE PARK, N.C., June 09, 2020 (GLOBE NEWSWIRE) -- Biotalys NV, a transformative food and crop protection company, today announced the expansion of its executive team and e...

Mainstay Medical Announces Reimbursement Approval for ReActiv8 in Australia

June 08, 2020 02:15 AM Eastern Daylight Time DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc (“Mainstay” or the “Company”), today announced that ReActiv8, its implantable restorative neurostimulation system to treat disabling Chronic Low Back Pain, has been approved for inclusion in the Prostheses List of re...

Shockwave Medical Announces That CMS Has Created New Codes for Intravascular Lithotripsy

Centers for Medicare & Medicaid Services Issues New Codes for Peripheral Intravascular Lithotripsy Performed in Hospital Outpatient and Inpatient Settings SANTA CLARA, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascula...

1 2 3 4